Anthem Biosciences per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
₹10.25₹10.55
₹10.15₹10.43
₹54.16₹54.16
₹35.65₹37.82
—₹15.03
₹11.27₹11.27
56.256.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ANTHEM₹805.70

Anthem Biosciences Ltd.

· Pharma & Health
₹ CrorePeersSYNGENEDIVISLABGLAXOAJANTPHARMIPCALABABBOTINDIAMEDANTAGLENMARKMcap ₹45,257 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS10.5510.25
Diluted EPS10.4310.15
Book Value per Share54.1654.16
Revenue per Share37.8235.65
Cash Flow per Share15.03—
Free Cash Flow per Share11.2711.27
Shares Outstanding (cr)56.256.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.